Andrea Bushnell
Nurse Practitioner · Springfield, ILNPI 1356904148
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,004 of the $14,894 with a category attached, or 73.9%. It is spread thinly across 58 manufacturers, the largest accounting for just 17.5%. Reporting peaked in 2024 at $7,415 and has fallen 67.0% since, to $2,444 in 2025. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 576 payments — averaging $25.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$3K
- Abbott$2K
- AbbVie$1K
- AstraZeneca$692
- Lilly USA, LLC$654
- Teva Pharmaceuticals USA, Inc.$612
- plus $7K from 52 others
What the payments were for
- Consulting fees$2252%
- Speaking & faculty fees$130%
- Travel & lodging$3,26422%
- Food & beverage$11,00474%
- Education$3893%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$2,136
- INFINITY$1,861
- IPS - Mini-Bag Plus$225
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$139
- VYEPTI$123
- NOURIANZ$120
- Hizentra$110
- ULTOMIRIS$100
How this compares
$14,894 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 43 | $343,990 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 28 | $161,490 |
| Nurtec OdtRimegepant Sulfate | 44 | $80,188 |
| QuliptaAtogepant | 30 | $56,174 |
| RexultiBrexpiprazole | 25 | $37,252 |
| BotoxOnabotulinumtoxina | 21 | $28,435 |
| KeppraLevetiracetam | 12 | $21,191 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $14,894 |
| LamictalLamotrigine | 11 | $14,547 |
| Emgality SyringeGalcanezumab-Gnlm | 13 | $14,449 |
| Lacosamide | 65 | $12,158 |
| Memantine Hcl | 246 | $7,143 |
| Pregabalin | 62 | $6,620 |
| Gabapentin | 212 | $6,415 |
| Donepezil Hcl | 307 | $4,028 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $485 | $343,99043 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $69 | $161,49028 claims |
| AbbVieQulipta, Botox | $1,148 | $84,60951 claims |
| PfizerNurtec Odt | $268 | $80,18844 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Springfield
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
- Kristine WarnesNaperville$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.